DT&CRO Co

DT&CRO Co P/TBV

The Price to Tangible Book Value (P/TBV) of DT&CRO Co (383930.KQ) as of Oct 16, 2026 is 1.58. In the previous year, Price to Tangible Book Value (P/TBV) was 0.96 — a change of 64.33% (higher).

P/TBV

1.58

YoY

64.33%

Last updated:

Price to Tangible Book Value (P/TBV) of DT&CRO Co is 2024 1.58 . Price to Tangible Book Value (P/TBV) of DT&CRO Co was 2023 0.96 . It decreases by 64.33% higher compared to the previous year.

The DT&CRO Co P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2019
-14.37 KRW
Jan 1, 2020
-9.72 KRW
Jan 1, 2022
0.96 KRW
Jan 1, 2024
1.58 KRW
The DT&CRO Co P/TBV history
YEARP/TBVYoY
1.58+64.33%
0.96-109.87%
-9.72-32.38%
-14.37—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DT&CRO Co Stock analysis

What does DT&CRO Co do? DT&CRO Co Ltd is a South Korean company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Based in Yongin, the company has 277 employees and completed its initial public offering (IPO) on November 11, 2022. DT&CRO Co Ltd provides non-clinical and clinical trial services for pharmaceuticals, medical devices, food, chemicals, and cosmetics. The company also offers analysis, efficacy evaluation, and related services. Its headquarters are located in Yongin, Gyeonggi-Do, South Korea. The company's website is www.dtncro.com. DT&CRO Co Ltd is engaged in research and development activities related to medicine and pharmaceuticals, though specific details about its R&D focus or product offerings are not provided in the available information. The company operates as a service provider in the life sciences sector, supporting various industries through trial services and analytical solutions. As a publicly traded company, it is listed under the ticker symbol 383930.KQ with ISIN KR7383930005. The company's operations are centered on delivering specialized services to clients in the pharmaceutical and related industries, emphasizing both non-clinical and clinical trial support. DT&CRO Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DT&CRO Co stock

Price to Tangible Book Value (P/TBV) of DT&CRO Co is 1.58 in 2024.

Price to Tangible Book Value (P/TBV) of DT&CRO Co changed from 0.96 to 1.58, representing a 64.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) DT&CRO Co since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s DT&CRO Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — DT&CRO Co

All Key Metrics — DT&CRO Co